The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy

Abstract Background First-line chemotherapy combined with bevacizumab is one of the standard treatment modes for patients with advanced non-small cell lung cancer (NSCLC). Thoracic radiotherapy (TRT) can provide significant local control and survival benefits to patients during the treatment of adva...

Full description

Bibliographic Details
Published in:Radiation Oncology
Main Authors: Feihu Chen, Jiling Niu, Min Wang, Hui Zhu, Zhijun Guo
Format: Article
Language:English
Published: BMC 2024-05-01
Subjects:
Radiation pneumonitis
Bevacizumab
Thoracic radiotherapy
Non-small cell lung cancer
Online Access:https://doi.org/10.1186/s13014-024-02458-x

Internet

https://doi.org/10.1186/s13014-024-02458-x

Similar Items